gadolinium DOTA meglumine
- CAS NO.：92943-93-6
- Empirical Formula: C23H42GdN5O13
- Molecular Weight: 753.86
- MDL number: MFCD01725577
- SAFETY DATA SHEET (SDS)
- Update Date: 2025-04-17 18:22:24
What is gadolinium DOTA meglumine?
The Uses of gadolinium DOTA meglumine
Gadolinium Dota Meglumine is used in the preparation of Macrocyclic Gadolinium-?Based Contrast Agents.
Definition
ChEBI: An organoammonium salt obtained by reaction of gadoteric acid with one equivalent of 1-deoxy-1-(methylamino)-D-glucitol (meglumine). It is used in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of pa ients ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system.
Safety information for gadolinium DOTA meglumine
New Products
502-97-6 DL-Lactide Polycaprolactone, CL10015 , M.W: 190,000 – 240,000 da , I.V: 1.30 – 1.70 dL/g Jone's Reagent Proparzyl bromide methyl vinyl sulfone Tetra decyl ammonium bromide Pyridine, 3-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl-, (2E)-2-butenedioate (1:1) Di-tert-butyl dicarbonate 5-NITRONICOTINIC ACID N-NITROSO QUETIAPINE EP IMPURITY B ARTICAINE CHLORO COMPOUND ROSUVASTATIN IMPURITY N 2-((2-AMINO-6-METHYLPHENYL)THIO)BENZOIC ACID UNKNOWN MATERIAL HYDROXY DAPAGLIPZOLIN Bis(4-nitrophenyl) carbonate Tert-butyl-4(1H-benzo[d]imidazole-2-yl)piperidine-1-carboxylate 4-(3-Methylphenyl)Amino-3-Pyridine Sulfonamide tert-Butyl 4-bromo-5,6-dihydropyridine-1(2H)-carboxylate 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine- 2,6(3H,7H)-dione 2-Piperidin-4-yl-1H-benzimidazole Poly(DL-Lactide), DL10014E,M.W:190,000 – 240,000 da,I.V:1.30-1.70 dL/g L-PLA-PEG ,L1001P1, M.W:PLA : ~10,000 da PEG: ~1500 daRelated products of tetrahydrofuran
You may like
-
92943-93-6 Gadoterate Meglumine 98%View Details
92943-93-6 -
24980-41-4 ≥ 99.5%View Details
24980-41-4 -
24980-41-4 Polycaprolactone, CL1002 , M.W: 7,000 – 17,000 da , I.V: 0.16 – 0.24 dL/g ≥ 99.5%View Details
24980-41-4 -
Polycaprolactone, CL1005 , M.W: 43,000 – 63,000 da , I.V: 0.50 – 0.70 dL/g ≥ 99.5%View Details
24980-41-4 -
PCL-PEG-PCL Triblock copolymer,CL1001P1, M.W:PCL (Mw) : ~10,000 da, PEG (Mw) : ~1500 da ≥ 99.5%View Details
24980-41-4 -
Polycaprolactone, CL10010 , M.W: 90,000 – 140,000 da , I.V: 0.90 – 1.20 dL/g ≥ 99.5%View Details
24980-41-4 -
Poly(DL-Lactide)-co-Glycolide, PLGA 75:25 DLLAGA 2E, M.W:7,000 – 17,000 da, I.V: 0.16 – 0.24 dL/g 34346-01-5 ≥ 99.5%View Details
34346-01-5 -
24980-41-4 Polycaprolactone, CL10015 , M.W: 190,000 – 240,000 da , I.V: 1.30 – 1.70 dL/g ≥ 99.5%View Details
24980-41-4
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.